CAPS

Capstone Holding Corp. NASDAQ Listed Jan 28, 1993

Basic Materials ·Construction Materials ·US · capstoneholdingcorp.com

$0.38

Mkt Cap $2.0M

52w Low $0.36 0.7% of range 52w High $3.29

50d MA $0.57 200d MA $0.90

P/E (TTM) -0.1x

EV/EBITDA -10.0x

P/B 0.2x

Debt/Equity 2.3x

ROE -170.5%

P/FCF -0.9x

RSI (14) —

ATR (14) —

Beta -1.27

50d MA $0.57

200d MA $0.90

Avg Volume 2.0M

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

CIK (SEC)

887151

Phone

602-286-5520

1275 West Washington Street · Alsip, IL 60803 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Nov 18, 2025	AMC	0.12	-0.35	-391.7%	0.90	+3.3%	-1.6%	-10.7%	-5.5%	+8.3%	-2.8%	—
Aug 15, 2025	AMC	-0.07	-0.13	-85.7%	1.24	+0.0%	-8.1%	-4.4%	-6.4%	-1.0%	+8.9%	—
May 15, 2025	AMC	-1.10	-0.47	+57.3%	1.66	+66.3%	+47.6%	-14.7%	-5.7%	-1.0%	-2.1%	—
Apr 1, 2025	AMC	—	-7.00	—	2.34	+4.7%	+0.9%	-11.9%	-7.7%	-5.2%	+39.0%	—
Sep 30, 2024	AMC	—	0.22	—	3.25	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—
Jun 29, 2024	AMC	—	-2.42	—	—	—	—	—	—	—	—	—
Mar 30, 2024	AMC	—	-7.06	—	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-12.81	—	—	—	—	—	—	—	—	—
Sep 29, 2023	AMC	—	-3.86	—	7.50	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—
Jun 30, 2023	AMC	—	-0.49	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-7.07	—	18.50	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—

Data updated apr 24, 2026 11:49pm · Source: massive.com